ArticlemedRxiv : the preprint server for health sciences2021

Enisamium is an inhibitor of the SARS-CoV-2 RNA polymerase and shows improvement of recovery in COVID-19 patients in an interim analysis of a clinical trial.

Olha Holubovska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.